About Kapil Khandelwal KK
Popularly known as Father of ‘Quant Offshore Hedge Fund Investing’ in India amongst the Hedge Fund Managers in India and abroad, Kapil has earned recognition to be amongst the few handful Indians approved by the United Kingdom’s Financial Conduct Authority (FCA) approved board members’ list to serve the boards of funds, banks and financial institutions. He is a successful angel investor, venture capitalist and expert in health sciences, education, agri, clean tech and information communications and technology (ICT). KK runs a popular podcast QuoteUnQuote With KK
Bloomberg: https://www.bloomberg.com/profile/person/21106690
My Associate Funds
EquNev Capital
EquNev Capital focuses on providing customised capital and funding advice in the areas of investment banking, early stage and incubation fund management focused on India and the emerging markets (GCC, Africa and ASEAN)
El Toro Finserve LLP managed Healthcare Sustainability and Impact Funds are India’s first dedicated healthcare funds that invests in Indian healthcare providing non-dilutive and long tenure funds for growth
El Toro Finserve LLP - Healthcare Sustainability and Impact Funds
ASK Family Office
ASK Family Office – Growing for Future!
This is the Family Office of KK where he drives future generation-led initiatives
QuoteUnquote with KK – Podcast
QuoteUnquote with KK
QuoteUnquote with KK is a podcast show that organises a virtual fireside chat with the thought leaders around the world on various economic and investing issues.
Latest QuoteUnQuote With KK
Beauty with Brains : Can Beauty be Smarter?
QuoteUnQuote with KK and Naiyya Saggi, Co Founder, the Good Glam Group, an Indian beauty unicorn and Founder, BabyChakra
Rebooting Age: Long-Living India
QuoteUnQuote with KK and Dr. Deepak Kumar Saini, Convener, Longevity India and Professor, Dept. of Developmental Biology & Genetics Indian Institute of Science (IISC) https://longevity.iisc.ac.in/
More on: Rebooting Age: Long-Living India | Kapil Khandelwal KK
Bharatvarsh: The Destinations for Spiritual Wellness Journeys
QuoteUnQuote with KK and Dr. Devdutt Patnaik, India’s leading mythologist, speaker, illustrator and author, known for his writing on Hindu sacred lore, legends, folklore, fables and parables www.Devdutt.com
More on: Bharatvarsh – Pilgrim Nation: The Land Of Spiritual Wellness Travel | Kapil Khandelwal KK
Mooring Around the Future of Chips in AI-dominated India
QuoteUnquote with KK and Nitin Dahad, Tech Evangelist, Editor embedded.com, Writer
More on: Mooring Around The Future Of Chips In AI-dominated India | Kapil Khandelwal KK
Making Life Happenings into Compelling Stories
QuoteUnquote with KK and Indranil Chakraborty, Author, Corporate Coach, Master Storyteller,
https://storyworks.in/
Growing the Investments in India Stack and Ecommerce
QuoteUnquote with KK and Kevin T Carter, Founder and Chief Investment Officer, EMQQ Global, An Emerging Markets and Indian Exchange Traded Fund (ETF) on NYSE
More on: Investment In Indian Ecommerce Archives | Kapil Khandelwal KK
My Social Playlist
KK loves to hear hard rock during his daily morning walk. He shares a social message through the song he listens here. Enjoy the current affairs through the songs and music from his social playlist
KK on his walk listening to the Music Playlist
KK’s Blogs
KK has played leadership and advisory roles in several think tanks, industry bodies in India and abroad in drafting and guiding public policies and regulations. He shares his thoughts and ideas through his blog page
My Articles Book Shelf
Over the years, KK has written several articles and columns in new papers and magazines on various issues and topics of interest. The collection of his writings are in the bookshelf
Announcement and Updates
Express Pharma Q&A : These 40 bests would deliver $30 – $50 bn additional growth to healthcare sector by 2029
Business Standard : Anti-Ageing Tech Likely to Shape Heathcare Demand in Coming Years
Business Standard - Anti Ageing Tech Likely to Shape Heathcare Demand in Coming Years
Express Pharma: 2024: Healthcare and Life Sciences Investment Outlook